0
     

Report Added
Report already added
Analgesics in Saudi Arabia

Analgesics in Saudi Arabia

Analgesics continued to see good sales over 2019 thanks to the 2018 ban on selling antibiotics without a prescription. As a result, Saudi consumers continued to use more analgesics whenever they experience pain whether it is due to headaches, fever or inflammation as they can no longer buy antibiotics without going to a doctor and getting a prescription. In addition, the organisation of awareness campaigns by the Ministry of Health about the importance of rationing the use of antibiotics also co...

Analgesics in Saudi Arabia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2014-2018, allowing you to identify the sectors driving growth. Forecasts to 2023 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Analgesics market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Analgesics in Saudi Arabia

Headlines
Prospects
Analgesics Continue To Profit From Ban on the Sale of Antibiotics Without Prescription
Topical Analgesics/anaesthetic Sees Slightly Better Growth Thanks To Introduction of New Products
Adult Ketoprofen, Adult Naproxen and OTC Triptans Likely To Come Under Further Regulation in the Future
Competitive Landscape
Gsk Consumer Healthcare Is New Leader Following Merger
Cigalah Group Launches New Nurofen Variants Over 2019
Sfda Continues To Keep An Eye on Quality in 2019
Category Data
Table 1 Sales of Analgesics by Category: Value 2014-2019
Table 2 Sales of Analgesics by Category: % Value Growth 2014-2019
Table 3 NBO Company Shares of Analgesics: % Value 2015-2019
Table 4 LBN Brand Shares of Analgesics: % Value 2016-2019
Table 5 Forecast Sales of Analgesics by Category: Value 2019-2024
Table 6 Forecast Sales of Analgesics by Category: % Value Growth 2019-2024
Executive Summary
Higher Prices Continue To Hinder Value Growth in 2019
Increasing Regulation Dampens Present and Future Growth
Gsk Consumer Healthcare Leads Thanks To Well-known Brands and Saudi Investment
New Players Enter Internet Retailing in 2019 Adding New Dynamism To the Market
Value Sales To Pick Up Despite Higher Prices and Expatriates Leaving the Country
Market Indicators
Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2014-2019
Table 8 Life Expectancy at Birth 2014-2019
Market Data
Table 9 Sales of Consumer Health by Category: Value 2014-2019
Table 10 Sales of Consumer Health by Category: % Value Growth 2014-2019
Table 11 NBO Company Shares of Consumer Health: % Value 2015-2019
Table 12 LBN Brand Shares of Consumer Health: % Value 2016-2019
Table 13 Distribution of Consumer Health by Format: % Value 2014-2019
Table 14 Distribution of Consumer Health by Format and Category: % Value 2019
Table 15 Forecast Sales of Consumer Health by Category: Value 2019-2024
Table 16 Forecast Sales of Consumer Health by Category: % Value Growth 2019-2024
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
Definitions
Sources
Summary 1 Research Sources

Kindly Fill The Form Below

Report Title: Analgesics in Saudi Arabia


Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW